Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antihistamines in Eosinophilic Esophagitis
NCT04248712Phase 2Terminated
- Sponsor
- Mayo Clinic
- Start
- Jul 2020
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of famotidine, loratadine in eosinophilic esophagitis (EoE), sponsored by Mayo Clinic. Started Jul 2020; status: terminated.
02
Drugs
famotidineloratadine
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on NCT04248712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04248712.